Martin Shkreli ban from pharmaceutical industry upheld by US court
Published
Martin Shkreli, the “pharma bro” entrepreneur who astronomically increased the price of a life-saving drug by more than 4,000% and became a symbol of corporate Wall Street greed, cannot return to the pharmaceutical industry, a court has ruled. A federal appeals court in New York upheld his…
#martinshkreli #manhattan #shkreli #ftc #illinois #northcarolina #ohio #pennsylvania #virginia #daraprim